Repaglinide 1 mg effectively lowers blood glucose levels by stimulating insulin release from the pancreas. Its efficacy is most pronounced in patients with mild to moderate type 2 diabetes who haven’t achieved adequate glycemic control with lifestyle modifications alone. However, its short half-life necessitates multiple daily doses, potentially impacting adherence.
Alternative Medications
Consider metformin as a first-line treatment for most type 2 diabetes patients. If metformin is unsuitable or insufficient, alternative medications include sulfonylureas (e. g., glipizide), DPP-4 inhibitors (e. g., sitagliptin), GLP-1 receptor agonists (e. g., liraglutide), SGLT2 inhibitors (e. g., empagliflozin), or insulin therapy. The choice depends on individual patient factors including age, other medical conditions, and treatment goals.
Long-Term Management Strategies
Regular blood glucose monitoring remains critical. Patients should closely follow their doctor’s recommendations regarding diet, exercise, and medication. Annual or semi-annual check-ups are recommended to assess efficacy and monitor potential side effects, including hypoglycemia and weight gain. Lifestyle modifications, such as a balanced diet and regular physical activity, are fundamental for long-term diabetes management, complementing medication efficacy.
